Blanchard D, Navenot J M, Petit-Le Roux Y, Willem C, Loirat M J
Etablissement de Transfusion Sanguine de Loire Atlantique/Vendée, Site de Nantes, France.
Transfus Clin Biol. 1997;4(1):131-4. doi: 10.1016/s1246-7820(97)80028-6.
A series of 18 monoclonal antibodies directed to complement regulatory proteins were investigated by flow cytometry and immunoblotting. Seventeen antibodies are directed against a phosphatidyl inositol-linked glycoprotein since they show a dual population of erythrocytes from a paroxysmal nocturnal haemoglobinuria (PNH) patient. From this group, 6 antibodies revealed a 65-70 kDa band on immunoblots allowing their identification as anti-DAF (Decay Accelerating Factor; CD55 antigen), and 11 bound to a 20 kDa molecule corresponding to MIRL (Membrane Inhibitor of Reactive lysis, CD59 antigen). One antibody revealed an homogeneous population from the PNH patient and bound to a 200 kDa band on immunoblot that might corresponds to the CR1 (Complement Receptor type 1; CD35).
通过流式细胞术和免疫印迹法对一系列18种针对补体调节蛋白的单克隆抗体进行了研究。17种抗体针对磷脂酰肌醇连接糖蛋白,因为它们在阵发性夜间血红蛋白尿(PNH)患者的红细胞中显示出双群体。在该组中,6种抗体在免疫印迹上显示出65 - 70 kDa条带,使其被鉴定为抗衰变加速因子(DAF;CD55抗原),11种抗体与对应于膜反应性溶解抑制物(MIRL;CD59抗原)的20 kDa分子结合。一种抗体在PNH患者中显示出均匀群体,并在免疫印迹上与可能对应于补体受体1型(CR1;CD35)的200 kDa条带结合。